FUTRUE #Rethink Health
We unite the best talents to revolutionize healthcare.
#RethinkHealth
Futrue HeroFutrue Hero Mob
2008 Start-up. Now an international Healthcare Group.

While breakthroughs are being made in areas such as artificial intelligence and space travel, the healthcare sector is largely stagnating despite some individual successes. On average, it takes 13 years to develop a new medicine – twice as long as it took 30 years ago. It is high time for a fundamental change!

That is why I, Clemens Fischer, founded FUTRUE together with Madlena Hohlefelder – a group of companies that now includes over 20 companies and more than 90 pharmaceutical approvals. Among them are some of the fastest growing companies in the healthcare industry. We develop transformative medicines and technologies, taking a unique approach in the pharmaceutical industry: lean, highly specialized and independent teams of fewer than 180 employees per company develop new therapies in record time and bring them to market.

We rely on a new generation of dynamic talents who have the courage to challenge conventional thinking and break new ground. Previous pharmaceutical experience is not required.

Dr. Clemens Fischer
Founder & CEO FUTRUE
Futrue Founder Clemens Fischer
Our companies

A current example of FUTRUE's innovative strength is VERTANICAL – a leading biopharmaceutical company that, with a team of fewer than 150 employees, has achieved a breakthrough in pain medicine in just seven years with the development of the drug VER-01. For the first time, VER-01 offers a real alternative to opioids, which have a range of severe side effects, for the millions of people worldwide suffering from severe pain. Approval could come as early as July this year.

Leading global biopharmaceutical company developing innovative drugs for the treatment of chronic pain. With the development of the groundbreaking drug VER-01, VERTANICAL has reached a first milestone on the way to realizing its vision of a world without chronic pain. VERTANICAL is pursuing the goal of replacing opioids by 2030 with the pioneering new development VER-01 and establishing VER-01 as the leading therapy for chronic pain.

Pioneering company in the development and marketing of innovative probiotics, which has developed the market-leading medical product Kijimea Irritable Bowel Syndrome, among others. With the vision of establishing probiotics as the basis for a healthier and longer life, SYNformulas is pursuing the goal of developing Kijimea into the world's leading probiotics brand by 2028.

Listed OTC company with a broad portfolio of non-prescription medicines and dietary supplements with well-known brands such as Spalt, Formigran, Baldriparan and Restaxil. With the vision of creating a life free from daily ailments, PharmaSGP aims to alleviate the daily ailments of 100 million people and significantly improve their quality of life by 2030.

currently being founded

Pioneering biotech company developing a unique microbiome called “Mikro7” using laboratory technology to fundamentally treat serious diseases. With the vision of revolutionizing the treatment of serious diseases through the targeted transfer of artificial microbiomes, the company plans to use Mikro7 for the first time in clinical trials as early as 2025.

Research and development service provider that already conducts clinical trials significantly faster and at a fraction of the cost of big pharma or biotech. With the ambitious vision of halving the waiting time for innovative therapies, the company plans to conduct studies with a 50% shorter study time and at 30% of the cost of market-leading research service providers by 2027 at the latest.

International pharmaceutical media agency with strong expertise in print and TV as well as digital communication, including e-detailing and DTC online campaigns. With an annual gross media volume of more than 400 million euros and the vision of fundamentally changing communication to specialist groups and patients, EMCM plans to reach ten times more contacts by 2028 at only 20 % of today's costs.

Our Management

We are looking for people who are determined to make a difference, who are not deterred by setbacks and who set high standards for themselves and others. Previous pharmaceutical experience is not necessary for us.

01 Clemens Fischer
Dr. Clemens Fischer
Founder and CEO FUTRUE
02 Madlena Hohlefelder
Madlena Hohlefelder
CSO FUTRUE
03 David Rietbrock
David Rietbrock
CEO SYNformulas
04 Bastian Baasch
Bastian Baasch
CEO FUTRUE Research & Science and VERTANICAL
05 Sebastian Hach
Sebastian Hach
CCO/Managing Director of VERTANICAL
07 Michael Rudolf
Michael Rudolf
Board PharmaSGP
08 Peter Gerckens
Peter Gerckens
Board PharmaSGP
09 Benno Stoecklein
Dr. Benno Stöcklein
Director Commercial PharmaSGP
11 Max Dingler
Dr. Max Dingler
Director R&D and QA&RA
12 Jan Mueller Goedeke
Jan Müller-Gödeke
CEO FUTRUE Group Services
13 Matthias Wenninger
Dr. Matthias Wenninger
CEO EMCM
22 Kai Winselmann
Dr. Kai Philipp Winselmann
Managing Director / Chief Digital Marketing Officer SYNformulas
14 David Theodor Schmidt
David Theodor Schmidt
Director Marketing SYNformulas
15 Janin Grajcarek
Dr. Janin Grajcarek
Director Clinical Strategy VERTANICAL
16 Tobias Ostermann
Tobias Ostermann
Director Operations VERTANICAL
17 Alexander Von Falkenhausen
Alexander von Falkenhausen
Director Clinical Operations VERTANICAL
19 Fabian Lorson
Dr. Fabian Lorson
Director BD and M&A
20 Mareike Hierl
Mareike Hierl
Director Legal
23 Gabriel Kuntz
Gabriel Kuntz
Venture Manager SYNformulas
Load more
Our values

Corporate values are at the heart of every successful organization. Our values not only serve as a guide for our behavior and decisions, but also shape our corporate culture and identity.

We believe in the power of small A-teams

We are convinced that a small organisation of top-performers can achieve anything.

We strive for excellence

We hold ourselves to the highest standards in everything we do.
Icon Persistence

We embrace persistence

We believe persistence drives achievement. We refuse to accept "no" as an answer.
We uphold full transparency
We speak up and voice our opinions clearly.
We continuously improve ourselves
We consistently question ourselves and challenge our views with credible persons.
Icon Safety
We act with integrity

We stay away from anything illegal, dishonest, or immoral.

#RethinkHealth with us!

Are you interested and want to revolutionize the pharmaceutical and healthcare industry together with us? Then find out more about the FUTRUE culture now or apply directly for one of our vacancies. Previous experience in the pharmaceutical or healthcare industry is not required. What is more important to us is your drive, your willingness to learn and your communication and analytical skills.

Futrue Recruiting

Follow us on LinkedIn!

Follow
Futrue LinkedinFollow